Skip to main content

Lung Cancer Podcast

The Increasing Role of Perioperative Therapy in Early Stage NSCLC
Oncology Podcast Series

The Increasing Role of Perioperative Therapy in Early Stage NSCLC

By Charu Aggarwal
Management of Small Cell Lung Cancer
Oncology Podcast Series

Management of Small Cell Lung Cancer

By Jacob Sands, MD
Molecular Testing and the Implications for 1L Therapy in Stage IV EGFRm NSCLC
Oncology Podcast Series

Molecular Testing and the Implications for 1L Therapy in Stage IV EGFRm NSCLC

By Charu Aggarwal
Advances in the Management of Stage III NSCLC – Impact of the LAURA Clinical Trial
Oncology Podcast Series

Advances in the Management of Stage III NSCLC – Impact of the LAURA Clinical Trial

By Charu Aggarwal
Advances in Recurrent NSCLC Dato DXd
Oncology Podcast Series

Advances in Recurrent NSCLC – Dato-DXd

By Jacob Sands, MD
Advances in the Management of Extensive Small Cell Lung Cancer
Oncology Podcast Series

Advances in the Management of Extensive Small Cell Lung Cancer

By Stephen V. Liu, MD
Omni Oncology SCLC July 2024
Oncology Podcast Series

Extensive Small Cell Lung Cancer

By Jacob Sands, MD
ASCO News
Oncology Podcast Series

ASCO Conference Coverage – Lung Cancer

By Charu Aggarwal and Omar Elghay MD
Perioperative therapy and esNSCLC – ALINA Improves outcomes for ALK mutated NSCLC’s
Oncology Podcast Series

Perioperative therapy and esNSCLC – ALINA Improves outcomes for ALK mutated NSCLC’s

By Charu Aggarwal and Eric Vallieres, MD, FRCSC
Molecular Testing and the Implications for Management of ES-NSCLC copy
Oncology Podcast Series

Perioperative Therapy in Early Stage NSCLC – Implications for Molecular Testing

By Brendon M. Stiles MD and Charu Aggarwal
The emerging role of CT DNA and the management of early stage breast cancer copy
Oncology Podcast Series

The Emerging Role of Antibody Drug Conjugates (ADC) in Advanced NSCLC

By Jacob Sands, MD
Molecular Testing and the Implications for Management of ES-NSCLC
Oncology Podcast Series

Perioperative Therapy in Early Stage NSCLC- Implications for Molecular Testing

By Charu Aggarwal and Brendon M. Stiles MD
Aggarwal Kucharczuk
Oncology Podcast Series

Molecular Testing and Implications for Adjuvant Therapy in Early Stage NSCLC

By Charu Aggarwal
The use of ctDNA for molecular residual disease assessment and Immunotherapy Monitoring in NSCLC
Oncology Podcast Series

The use of ctDNA for molecular residual disease assessment and Immunotherapy Monitoring in NSCLC

By Dr. Natalie Vokes
MolecularTesting1620
Oncology Podcast Series

Molecular Testing and Implications for Adjuvant Therapy in Early Stage NSCLC

By Charu Aggarwal
Post ASCO Update on Chem-IO in Early Stage NSCLC
Oncology Podcast Series

Post ASCO Update on Chem-IO in Early Stage NSCLC

By Charu Aggarwal
Aggarwal Kucharczuk
Oncology Podcast Series

Post ESMO Update on IMPower Clinical Trial in Early Stage NSCLC

By Charu Aggarwal and Dr. John Kucharczuk
Aggarwal ADAURA
Oncology Podcast Series

Five Year Update on ADAURA Clinical Trial of Tagrisso in EGFR Early Stage NSCLC

By Charu Aggarwal
PerioperativeTherapyAggarwal
Oncology Podcast Series

Perioperative Therapy in Early Stage NSCLC- Implications for Molecular Testing

By Charu Aggarwal
Implications of Early Molecular Testing on Perioperative Therapy in Early Stage NSCLC
Oncology Podcast Series

Implications of Early Molecular Testing on Perioperative Therapy in Early Stage NSCLC

By Charu Aggarwal
Aggarwal Kucharczuk
Oncology Podcast Series

Adjuvant therapy for Early Stage Lung Cancer – Case Based Discussion for Patient with Stage 1B NSCLC

By Charu Aggarwal and Dr. John Kucharczuk
Molecular Testing and the Implications for Management of ES-NSCLC
Oncology Podcast Series

Molecular Testing and the Implications for Management of ES-NSCLC A Case Base Discussion

By Charu Aggarwal and Brendon M. Stiles MD